Taipei Exchange - Delayed Quote TWD

Bioteque Corporation (4107.TWO)

125.00
-0.50
(-0.40%)
At close: 1:30:40 PM GMT+8
Loading Chart for 4107.TWO
  • Previous Close 125.50
  • Open 124.50
  • Bid 124.50 x --
  • Ask 125.50 x --
  • Day's Range 124.50 - 125.50
  • 52 Week Range 101.00 - 147.50
  • Volume 24,607
  • Avg. Volume 116,739
  • Market Cap (intraday) 8.662B
  • Beta (5Y Monthly) 0.22
  • PE Ratio (TTM) 16.21
  • EPS (TTM) 7.71
  • Earnings Date Aug 5, 2025 - Aug 11, 2025
  • Forward Dividend & Yield 5.00 (3.98%)
  • Ex-Dividend Date Jul 28, 2025
  • 1y Target Est --

Bioteque Corporation manufactures and sells medical devices in Asia, South America, North America, and internationally. The company provides medical disposables for use in hemodialysis access, endovascular treatment, and other fields. It offers dialysis products, including hemodialysis bloodlines, A.V.F. needles, and hemodialysis cathers; interventional radiology products, such as pigtail drainage catheter sets, introducer sets, connecting tubes, drainage bags, and radiopaque dilators; urology products comprising ureteral stent sets and urine collection bags; and IV administration products, such as PVC IV infusion bags, PVC bags, and twist-off ports. In addition, the company provides respiratory care products, such as closed suction catheters and endotracheal tubes; vascular access products comprising angiographic catheters, PTA balloon dilatation catheters, sheath introducers, guidewires, high pressure connecting tubes, PTCA balloon dilatation catheter-rapid exchange products, manifolds, and Y connectors; and medical components, including dialyzer connectors and caps, recirculating connectors with cap, rotating luer lock connectors, pump and T connectors, female luers, injection sites, luer lock and chamber caps, drip chambers, filters, clamps, pressure pillows, safeline HDF components, chamber assembly, and transducer protectors, as well as medical masks. Bioteque Corporation was incorporated in 1991 and is headquartered in Taipei, Taiwan.

www.bioteq.com.tw

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 4107.TWO

View More

Performance Overview: 4107.TWO

Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

4107.TWO
1.21%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
5.34%

1-Year Return

4107.TWO
1.93%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
2.67%

3-Year Return

4107.TWO
29.96%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
35.05%

5-Year Return

4107.TWO
20.53%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
98.07%

Compare To: 4107.TWO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 4107.TWO

View More

Valuation Measures

Annual
As of 5/20/2025
  • Market Cap

    8.70B

  • Enterprise Value

    7.65B

  • Trailing P/E

    16.28

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.18

  • Price/Book (mrq)

    2.69

  • Enterprise Value/Revenue

    3.65

  • Enterprise Value/EBITDA

    8.84

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    25.64%

  • Return on Assets (ttm)

    8.68%

  • Return on Equity (ttm)

    17.15%

  • Revenue (ttm)

    2.09B

  • Net Income Avi to Common (ttm)

    537.11M

  • Diluted EPS (ttm)

    7.71

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.75B

  • Total Debt/Equity (mrq)

    16.84%

  • Levered Free Cash Flow (ttm)

    613.52M

Research Analysis: 4107.TWO

View More

Company Insights: 4107.TWO

Research Reports: 4107.TWO

View More

People Also Watch